SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-080975
Filing Date
2014-11-14
Accepted
2014-11-14 16:06:17
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19881_110q.htm 10-Q 746583
2 EX-31.1 a14-19881_1ex31d1.htm EX-31.1 9895
3 EX-31.2 a14-19881_1ex31d2.htm EX-31.2 9836
4 EX-32.1 a14-19881_1ex32d1.htm EX-32.1 5570
5 EX-32.2 a14-19881_1ex32d2.htm EX-32.2 5526
  Complete submission text file 0001104659-14-080975.txt   4902849

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ontx-20140930.xml EX-101.INS 638970
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20140930.xsd EX-101.SCH 46406
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20140930_cal.xml EX-101.CAL 40495
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20140930_def.xml EX-101.DEF 148344
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20140930_lab.xml EX-101.LAB 436015
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20140930_pre.xml EX-101.PRE 283284
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 141224062
SIC: 2834 Pharmaceutical Preparations